SCHEMBL6986222

SCHEMBL6986222

CC(C)(C)OC(=O)N1CC2CC(CN(CCCC(O)c3ccc(C#N)cc3)C2)C1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.42
HRH1 P35367 3/20 0.40
DRD3 P35462 3/20 0.40
LMNA P02545 2/20 0.40
HTR2A P28223 2/20 0.40
EGLN2 Q96KS0 2/20 0.40
AR P10275 1/20 0.40
CNR1 P21554 1/20 0.40
APEX1 P27695 1/20 0.40
PDE4A P27815 1/20 0.40
HTR2B P41595 1/20 0.40
BLM P54132 1/20 0.40
KCNH2 Q12809 1/20 0.40
PDE3A Q14432 1/20 0.40
DRD2 P14416 2/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CACNA1F O60840 1/20 0.39
HTR1A P08908 1/20 0.39
ADORA3 P0DMS8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6617937 0.85 GPR119 (0.38) GPR119HRH1DRD3HTR2AEGLN2
SCHEMBL6620971 0.84 HRH1 (0.41) HRH1DRD3LMNAHTR2ACNR1
SCHEMBL6621239 0.83 EPHX2 (0.43) GPR119HRH1EGLN2ARHRH2
SCHEMBL6622255 0.82 GPR119 (0.49) GPR119HRH1EGLN2HRH2EPHX2
SCHEMBL6733555 0.82 PDE4B (0.39) GPR119EGLN2EPHX2
SCHEMBL6739016 0.81 FAAH (0.44) HRH1DRD3LMNAHTR2ACNR1
SCHEMBL6621851 0.79 CETP (0.44) GPR119EGLN2EPHX2
SCHEMBL6622413 0.79 KCNH2 (0.48) GPR119HTR2AEGLN2KCNH2HSD17B10
SCHEMBL29388816 0.79 KCNH2 (0.48) GPR119HTR2AEGLN2KCNH2HSD17B10
SCHEMBL6619506 0.78 EPHX2 (0.51) GPR119HRH1HRH2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1192155-B1 NEW BISPIDINE COMPOUNDS USEFUL IN THE TREATMENT OF CARDIAC ARRHYTHMIAS ASTRAZENECA AB (SE) 2003-04-02 EP disclosed
US-6465481-B1 EXHIBIT ELECTROPHYSIOLOGICAL ACTIVITY; MAY BE MORE POTENT AND PRODUCE FEWER SIDE EFFECTS INCLUDING LOWER INCIDENCE OF PROARRHYTHMIAS SUCH AS TORSADES DE POINTES ASTRAZENECA AB (SE) 2002-10-15 US disclosed
CN-1370166-A Novel bispidine compounds useful in the treatment of cardiac arrhythmias ASTRAZENECA AB (SE) 2002-09-18 CN disclosed